Thimerosal removal device
View Patent ↗A device for the removal of heavy metals and heavy metal complexes, such as thimerosal, from medications is provided wherein the device comprises a dosing device or a solid support having at least one substantially purified metallothionein protein associated therewith. Additionally, methods to remove thimerosal from medications are provided.
1. A device for the removal of thimerosal from a medication to be administered to a subject comprising:
a dosing device having associated therewith at least one substantially purified metallothionein protein, wherein said at least one substantially purified metallothionein protein binds said thimerosal from said medication resulting in a substantially thimerosal-free medication.
2. The device of claim 1 wherein said dosing device is selected from the group consisting of syringes, oral dosing syringes, oral dosing cups, inhalation devices, needles, needleless injection devices and opthalmologic administrative devices.
3. The device of claim 1 wherein said medication is selected from the group consisting of vaccines, immunogenic compositions, liquid pharmaceutical compositions, colloidal pharmaceutical compositions, suspension pharmaceutical compositions, aerosols and dry powders.
4. The device of claim 1 wherein said administration comprises a route of administration selected from the group consisting of intravenous injection, subcutaneous injection, intradermal injection, intramuscular injection, intravenous infusion, oral, inhalation, and intraocular.
5. The device of claim 1 wherein said dosing device provides a sterile environment.
6. The device of claim 1 wherein said dosing device removes thimerosal from said medication proximal in time to said administration.
7. The device of claim 1 wherein at least one interior surface of said dosing device has at least one substantially pure metallothionein protein coated thereon.
8. The device of claim 7 wherein said at least one substantially pure metallothionein protein is covalently linked to said interior surface.
9. The device of claim 7 wherein said at least one substantially pure metallothionein protein is coated on said interior surface in a polymeric coating.
10. The device of claim 1 wherein said at least one substantially pure metallothionein protein is bound to a solid support, said solid support associated with said dosing device.
11. The device of claim 10 wherein said at least one substantially pure metallothionein protein is bound to a solid support, said solid support disposed within said dosing device.
12. The device of claim 7 wherein said solid support is selected from the group consisting of filters, membranes, nanoparticles, beads, solid support particulates, and polymer coatings.
13. The device of claim 12 wherein said at least one substantially pure metallothionein protein is associated with a plurality of beads or nanoparticles, said plurality of beads or nanoparticles disposed within said dosing device.
14. The device of claim 12 wherein said solid support comprises a biocompatible polymer.
15. The device of claim 14 wherein said biocompatible polymer is selected from the group consisting of fluorinated polymers, polyolefins, polystyrene, substituted polystyrenes, polysulfones, polyesters, polyacrylates, polycarbonates; vinyl polymers, copolymers of butadiene and styrene, fluorinated ethylene-propylene copolymers, ethylenechlorotrifluoroethylene copolymers, nylon and mixtures thereof.
16. The device of claim 12 wherein said solid support is a filter.
17. The device of claim 1 wherein said at least one substantially purified metallothionein (MT) protein, or a portion thereof, is from an organism selected from the group consisting of mammals, fish, mollusks, echinoderms, crustaceans, reptiles, nematodes, grains, plants, yeast, and fungi.
18. The device according to claim 17 wherein said mammal is a human.
19. The device according to claim 17 wherein said mammal is a rabbit.
20. The device according to claim 17 wherein said crustacean is brine shrimp ( Artemia ).
21. The device of claim 1 wherein said MT protein has an amino acid sequence selected from the group consisting of SEQ ID NO. 2, SEQ ID NO. 4, SEQ ID NO. 11, SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 14, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 17, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21, SEQ ID NO. 21 and SEQ ID NO. 23.
22. A method of removing thimerosal from a medication to be administered to a subject comprising:
contacting a thimerosal-containing medication with at least one substantially purified metallothionein protein associated with a dosing device; and
administering the resulting substantially thimerosal-free medication to said subject.
23. A system for removing thimerosal from a medication to be administered to a subject comprising:
a device having at least one metallothionein protein associated therewith;
wherein passage of a medication through said device results in binding of said thimerosal to said metallothionein protein and a substantially thimerosal-free medication.
24. A device for the removal of thimerosal from a medication to be administered to a subject comprising:
a solid support associated with at least one substantially purified metallothionein protein, wherein said at least one substantially purified metallothionein protein binds said thimerosal from said medication resulting in a substantially thimerosal-free medication.